Scientists have developed six lines of humanized mice that can serve as valuable models for studying human cases of COVID-19. Scientists at La Jolla Institute for Immunology (LJI) have developed six ...
Platform data establish Modified DNA’s potential to overcome two of the barriers that have kept DNA from becoming a practical ...
VY1706 IND application process on track for Q2 2026; clinical entry expected H2 2026 -- Data from eight ASGCT presentations ...
Caloric restriction may help longevity—but comes with tradeoffs. A molecule called LCA might offer the upside, without the ...
AIRNA, a biotech company pioneering RNA-editing therapeutics to transform the lives of patients with rare and common conditions, is presenting new preclinical data on its therapeutic candidate AIR-001 ...
Multispecific antibody conjugated LNP/mRNA platform enables in vivo T-cell engineering and systemic B-cell depletion in animal models Data will ...
Mirai Bio, the innovation delivery partner for companies developing next generation nucleic acid medicines, today announced new preclinical data at the American Society of Gene and Cell Therapy (ASGCT ...
The Federal Circuit has revived Teva’s headache-treatment claims and highlighted a recurring litigation risk: Arguments that ...
GLP-1 weight-loss drugs alter brain circuits in the amygdala and dopamine system to reduce the motivation to seek out high-calorie foods.
Company closed PIPE financing with gross proceeds of up to $175 million, including the possible exercise of warrants, from long-term global investors. Proceeds are expected to fund the Company through ...
Aerobic glycolysis dominates lesion bioenergetics, with lactate promoting histone lactylation, M2 macrophage polarization, CD8⁺ T-cell exhaustion, EMT, and fibrosis that reinforce immune-protected ...
A resurfaced congressional hearing featuring Lauren Boebert, former Anthony Fauci and the National Institute of Allergy and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results